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Abstract
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Silica-based lectin microcolumns were developed and optimized for the separation and analysis of
glycoform fractions in alpha1-acid glycoprotein (AGP) based on both the degree of branching and
level of fucosylation. Concanavalin A (Con A) and Aleuria Aurantia lectin (AAL) were
immobilized onto HPLC-grade silica by reductive amination and packed into 2.1 mm i.d. × 5.0 cm
microcolumns. Factors examined for these microcolumns include their protein content, binding
capacity, binding strength and band-broadening under isocratic conditions (Con A) or step elution
conditions (AAL) and in the presence of various flow rates or temperatures. These factors were
examined by using experiments based on frontal analysis, zonal elution, peak profiling and peak
decay analysis. Up to 200 μg AGP could be loaded onto a Con A microcolumn and provide linear
elution conditions, and 100 μg AGP could be applied to an AAL microcolumn. The final
conditions for separating retained and non-retained AGP glycoform fractions on a Con A
microcolumn used a flow rate of 50 μL min−1 and a temperature of 50 °C, which gave a separation
of these fractions within 20 min or less. The final conditions for an AAL microcolumn included a
flow rate of 0.75 mL min−1, a temperature of 50 °C, and the use of 2.0 mM L-fucose as a
competing agent for elution, giving a separation of non-retained and retained AGP glycoforms in 6
min or less. The inter-day precisions were ± 0.7–4.0% or less for the retention times of the AGP
glycoforms and ± 2.2–3.0% or less for their peak areas.
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1.

Introduction
Alpha1-acid glycoprotein (AGP) is an acute phase glycoprotein that has a molar mass of 41–
43 kDa [1]. Human AGP contains a single polypeptide chain with 183 amino acids and two
disulfide bonds. Complex-type asparagine linked glycans are attached to this sequence at
five glycosylation sites and account for around 45% of the mass of AGP. The terminal sialic
residues of these glycans result in AGP having a low pI of 2.8–3.8 [1].
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There are several changes that can occur in AGP during disease. For instance, the normal
plasma concentration of AGP in humans ranges from 0.5 to 1.0 mg mL−1 (or 12–24 μM);
however, this concentration can increase by up to ten-fold during acute phase reactions [2].
In addition, an alteration in the glycosylation of AGP has been observed in a number of
diseases, such as a change in the degree of branching during acute or chronic infections
[3,4], liver disease [5,6], rheumatoid arthritis [7], and lung disease or lung cancer [8]. A
change in glycan branching has also been found in women during their menstrual cycles or
during estrogen-progesterone treatment [9]. An increase in fucosylation has been noted in
pancreatic cancer [10], hepatocellular carcinoma, and cirrhosis [11]. Hypersialylation of
AGP has been reported in ovarian cancer, lymphoma [12,13], hepatocellular carcinoma and
cirrhosis [11].
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The glycosylation or glycoforms of AGP have been examined by using capillary
electrophoresis [14,15] or mass spectrometry [16]. A number of studies have also employed
lectins (i.e., non-immune system carbohydrate-binding proteins) for such work[17–26]. One
common lectin that has been used is concanavalin A (Con A) from Canavalia ensiformis.
Con A can bind tightly to high-mannose type glycans or hybrid type glycans with mannose
branching, with weaker binding to complex type biantennary glycans [27]. Aleuria aurantia
lectin (AAL) is an alternative lectin that binds to α1–6, α1–3, and α1–4 linked fucose
residues [27]. Examples of lectin-based methods that have been used for AGP analysis are
crossed affinoimmunoelectrophoresis [4,7,17,18], affinity capillary electrophoresis [19,20],
lectin enzyme-linked immunosorbent assay [21], and affinity-based surface plasma
resonance [22]. Another such method is lectin affinity chromatography [23–26].
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In lectin affinity chromatography, a lectin is immobilized onto a chromatographic support
and used for the retention of given targets that contain complementary sugars within their
structure, such as glycopeptides, glycoproteins and glycolipids. Elution of the targets is
typically accomplished by adding a competing sugar to the mobile phase [28]. Lectin
affinity chromatography is commonly used for the enrichment of low abundance
glycoproteins and glycopeptides [29]. Prior work with lectin columns and AGP has
primarily used low-performance supports such agarose or polyacrylamide-agarose
composite beads [23–26], both which can be difficult to use directly as part of an HPLC
system due to their limited pressure stability and slow mass transfer properties [30].
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High performance affinity chromatography (HPAC) is a form of affinity chromatography in
which an immobilized binding agent is attached to small, rigid particles or some other type
of support that is capable of withstanding the high flow rates and operating pressures of
HPLC. This method is more suitable than traditional, low-performance affinity
chromatography for analytical applications due to its improved mass transfer properties,
speed, precision, and ease of automation [31]. In recent work, HPAC has been explored for
use with affinity microcolumns that have volumes in the low-to-mid microliter range [32].
Advantages that have been noted for these microcolumns are their need for only a minimal
amount of immobilized binding agent and small sample sizes, as well as their low nonspecific binding, fast analysis times and ease-of-use with on-line detectors or with other
columns in multi-dimensional systems [32,33]. In contrast to this, all previous reports that
have used Con A or AAL columns to bind and separate AGP glycoforms have involved long
separation methods and the use of fraction collection prior to the measurement and study of
the eluted AGP by other methods (e.g., mass spectrometry, capillary electrophoresis or
protein assays) [23–26,34].
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In this study, lectin microcolumns based on HPLC-grade porous silica will be developed and
examined for their use in the separation and direct analysis of AGP glycoform fractions
based on both the degree of branching and level of fucosylation. Both Con A and AAL will
be immobilized onto HPLC-grade silica and used in affinity microcolumns for
characterization by chromatographic techniques such as frontal analysis, zonal elution, peak
decay analysis, and peak profiling. The protein content and binding/elution properties of
these lectin microcolumns will be characterized during this process. The effect of altering
the flow rate, column temperature and use of a competing agent for elution will also be
considered. The final Con A and AAL microcolumns will be characterized in terms of their
reproducibility in retaining and measuring their non-retained and retained AGP glycoform
fractions. The properties and behavior of these methods will also be compared to those
reported in prior studies using other types of Con or AAL columns and supports for the
separation of AGP glycoform fractions [23–26,34].

2.

Experimental section

2.1

Materials
The AGP (from pooled human plasma, product no. G9885, ≥ 99% pure), L-fucose (> 99%),
(3-glycidoxypropyl)trimethoxysilane (≥ 98%), Con A (product C7275, type V, highly
purified), human serum albumin (HSA, product A1887, 96%, fatty acid free), ovalbumin (≥
Anal Chim Acta. Author manuscript; available in PMC 2020 October 31.
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98%), p-nitrophenyl α-D-mannopyranoside (p-NP-α-D-Man) and p-nitrophenyl α-Lfucopyranoside (p-NP-α-L-Fuc) were purchased from Sigma-Aldrich (St Louis, MO, USA).
The AAL (product L-1390, homogeneous by SDS-PAGE) was purchased from Vector
Laboratories (Burlingame, CA, USA). Nucleosil Si-300 silica (300 Å pore size, 5 μm
particle diameter) was purchased from Macherey-Nagel (Duren, Germany). A micro BCA
assay kit was obtained from Thermo Fisher Scientific (Waltham, MA, USA). All aqueous
solutions and samples were prepared using water from a Milli-Q Advantage A10 Water
Purification System (EMD Millipore Corporation, Billerica, MA, USA).
2.2

Apparatus
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Work with the high performance lectin microcolumns was performed with a Jasco HPLC
system (Tokyo, Japan) that contained two PU-2080 isocratic pumps, an AS-2057
autosampler, a CO-2067 column oven (i.e., for temperature control from 4 to 65 °C), and a
UV-2075 UV detector. A two position/six port valve (MX Series II, IDEX Health & Science,
Rohnert Park, CA, USA) was used to switch between the two isocratic pumps and their
mobile phases. The HPLC system and valve were controlled with ChromNav software from
Jasco. The chromatograms were analyzed with PeakFit 4.12 (Jandel Scientific Software, San
Rafael, CA, USA). The microcolumns were packed by using an HPLC slurry packer from
Chrom Tech (Apple Valley, MN, USA).
2.3

Preparation of lectin supports and microcolumns
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AAL and Con A were immobilized onto Nucleosil Si-300 silica based on reductive
amination [35]. Details of the immobilization procedures are provided in the Supplementary
Material. The amount of immobilized lectin was determined by using a BCA protein assay
[36]. For this assay, a small portion (i.e., around 4 mg) of each lectin support was washed
with water three times (e.g., to remove any possible interferences from the storage buffer,
such as Tris-HCl). The washed support was then dried at 50 °C prior to its use in the BCA
assay. Con A was used as the standard in the assay for the Con A silica and HSA was used
as a standard for the AAL support (note: HSA can be used as a general protein standard for
the BCA assay and has a molar mass similar to AAL) [37,38]. A control support was used as
the blank, and all measurements were made in triplicate. The total protein content in a
microcolumn was determined from these results by combining them with the total internal
volume of the microcolumn and the known packing density of the silica support (0.45 g/
cm3).
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Each support was downward packed into a 2.1 mm i.d. × 50 mm stainless steel column
(Note: other biocompatible materials for column construction can also be used; no problems
or issues with the use of stainless steel were noted in this particular study). The pressure
during this packing process was ramped at a rate of 400 psi per min, held at 4000 psi for 40
min and then reduced at a rate of 200 psi per min. A Con A microcolumn was packed by
using a 10 mM Tris-HCl (pH 7.4) buffer that contained 0.15 M NaCl, 0.50 mM CaCl2, 0.50
mM MgCl2 and 0.50 mM MnCl2 [39]. An AAL microcolumn was packed using 10 mM
Tris-HCl (pH 7.4) buffer containing 0.15 M NaCl [28]. These packing solutions were the
same as the application buffers that were to be used later with these supports, thus allowing
the immobilized ligands to maintain their binding activities throughout this process. Control
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microcolumns with identical dimensions were packed with the same procedure but using
water as the packing solution. These microcolumns were stored in their corresponding
packing buffers at 4 °C.
2.4

Frontal analysis
Frontal analysis was performed in triplicate to determine the binding capacities for the lectin
microcolumns [31]. The mean point of each breakthrough curve was determined by
obtaining the first derivative of this curve and using an exponentially-modified Gaussian fit
for the resulting derivative peak [31]. Identical conditions to those used with each lectin
microcolumn were used with a control microcolumn to correct for the void volume and nonspecific binding to the support (Note: no significant interactions were noted between the
control support and analytes that were used for frontal analysis).
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The frontal analysis experiments for Con A were performed by first equilibrating a Con A
microcolumn in 10 mM Tris-HCl (pH 7.4) buffer containing 0.15 M NaCl, 0.50 mM CaCl2,
0.50 mM MgCl2 and 0.50 mM MnCl2; this equilibration was done at 0.10 mL min−1 and
4 °C. A solution that contained 1.3 mM p-NP-α-D-Man, prepared in the same pH 7.4
application buffer, was then continuously applied to the microcolumn at 0.10 mL min−1 and
4 °C. This particular combination of temperature and mobile phase was used because the
equilibrium constant for p-NP-α-D-Man with Con A has been previously determined under
these conditions [40]. The given flow rate was selected to provide an easily-measured
difference in breakthrough times between the Con A and control microcolumns (i.e., ~ 1
min; see Supplementary Material). The elution of p-NP-α-D-Man was monitored at 400 nm,
which gave a response throughout the frontal analysis studies that was within the linear
range of the detector.
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Frontal analysis studies for AAL used an initial buffer for equilibration that consisted of 10
mM Tris-HCl (pH 7.4) containing 0.15 M NaCl and that was passed through an AAL
microcolumn at 0.10 mL min−1 and 25 °C (Note: this temperature and mobile phase
replicated previous conditions used to measure the equilibrium constant for p-NP-α-L-Fuc
with AAL) [41]. This same buffer was used to prepare a 1.6 mM solution of p-NP-α-L-Fuc,
which was then applied to the microcolumn continuously at 0.10 mL min−1 and 25 °C. The
elution of p-NP-α-L-Fuc was monitored at 400 nm, which gave a response within the linear
range of the detector throughout the frontal analysis study.
2.5

Chromatographic studies with AGP
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Work with a Con A microcolumn and AGP was performed under isocratic conditions, due to
the moderate binding strength that was observed for AGP to such a microcolumn under the
conditions used in this report (see discussion provided later in Sections 3.2–3.3). The mobile
phase was 10 mM Tris-HCl (pH 7.4) containing 0.15 M NaCl, 0.50 mM CaCl2, 0.50 mM
MgCl2 and 0.50 mM MnCl2. This mobile phase has been used in prior with Con A and is
known to allow good binding activity for this lectin [39]. A 20 μL portion was injected for
each AGP sample, as prepared in this mobile phase. Flow rates ranging from 0.025–0.10 mL
min−1 and temperatures of 10–50 °C were considered for this work (see Section 3.3 for final
optimized conditions). The elution of AGP was monitored at 280 nm. The resulting peaks

Anal Chim Acta. Author manuscript; available in PMC 2020 October 31.

Zhang and Hage

Page 6

Author Manuscript

for AGP were analyzed by using the linear progressive baseline correction of PeakFit 4.12
and an exponentially-modified Gaussian fit.
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Work with AGP on AAL microcolumns was performed using the step elution mode of
affinity chromatography [42], due to the strong retention observed for some AGP
glycoforms on this type of microcolumn (see Sections 3.4–3.6 for more details). The
application buffer was 10 mM Tris-HCl (pH 7.4) containing 0.15 M NaCl. This mobile
phase was also chosen based on prior studies with AAL and is known to allow good activity
for this lectin [28]. This same buffer was used to prepare samples containing various
concentrations of AGP. A 20 μL portion for each sample was injected. Flow rates of 0.20–
0.75 mL min−1 and a temperature of 10–50 °C were examined for use in the separation of
AGP glycoforms (see Section 3.6 for final conditions). L-Fucose was added into the
application buffer as a competing agent for sample elution. L-Fucose concentrations ranging
from 0.25 to 2.0 mM were considered. The AGP peaks were detected at 280 nm. The
resulting peaks for AGP were analyzed by using the linear progressive baseline correction of
PeakFit 4.12 and an exponentially-modified Gaussian fit.

3.

Results and Discussion

3.1

Initial characterization of lectin microcolumns
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Several factors were considered during the initial characterization of the lectin supports and
microcolumns that were employed in this study. The first item examined was the total
protein content of each support. This content was determined to be 88 (± 6) mg Con A per
gram of silica and 29.4 (± 1.7) mg AAL per gram of silica, respectively. For a 2.1 mm i.d. ×
5.0 cm microcolumn, these results corresponded to a total protein content of 6.9 mg (or 65
nmol) of Con A and 2.3 mg (or 32 nmol) of AAL (see Section 2.3 for more details on this
type of calculation). These protein contents were 1.8- to 2.2-fold higher than previouslyreported values of 40–50 mg Con A per gram of silica when using the same immobilization
method [34,39] and about 1.5-fold larger than a content of 20 mg AAL per gram of silica
that was obtained by using biotinylated AAL and silica containing immobilized avidin [34].
The higher protein content of the Con A support in this report versus Ref. [39] was probably
due to the smaller pore size and larger surface area of the silica that was present (i.e., 1000
vs. 300 Å, and 20 vs. 100 m2 g−1), allowing more room for the immobilization of Con A
[43], as well as the larger amount of Con A that was used for immobilization (i.e., 45 mg vs
8 mg per gram of silica). The Con A content of the support in this work was also higher than
in Ref. [34], even though this prior study used more Con A for immobilization (78 mg per
gram silica) and employed a non-conventional macroporous silica that had a two-fold higher
surface area than in this study. A higher AAL content was also noted in this report than in
Ref. [34], which was again probably due to the different immobilization conditions and
supports that were employed (e.g., the use of biospecific adsorption [34] vs. covalent
immobilization). One benefit of the higher protein contents that were achieved in this work
is that it allowed a corresponding reduction in the size of columns that could be used with
these supports to bind to AGP or other targets for Con A and AAL.
The amount of active Con A and AAL within these microcolumns was initially determined
by using frontal analysis. In these experiments, p-NP-α-D-Man was used as a model solute
Anal Chim Acta. Author manuscript; available in PMC 2020 October 31.
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with a known binding strength for Con A, having a dissociation constant (based on a singlesite model) of 18 μM at 4 °C and in the presence of pH 7.4, 20 mM Tris-HCl buffer
containing 0.15 M NaCl, 0.10 mM CaCl2, and 0.10 mM MnCl2 [40]. p-NP-α-L-Fuc was
utilized as an equivalent solute for AAL, having a dissociation constant, based on a singlesite model, of 9 μM at 25 °C and in the presence of pH 7.4, 10 mM Tris-HCl buffer
containing 0.8% NaCl [41]. These studies were carried out using applied concentrations for
both solutes that were 70- to 180-fold larger than their dissociation constants, resulting in
near saturation (i.e., > 99%) of the Con A or AAL microcolumns [44]. Some typical
chromatograms that were generated are shown in the Supplementary Material. It was found
that the amount of active binding sites for p-NP-α-D-Man in a Con A microcolumn was 89
(± 2) nmol, and the amount of binding sites for p-NP-α-L-Fuc in an AAL microcolumn was
152 (± 5) nmol. If it is assumed that there were a maximum of four possible binding regions
for p-NP-α-D-Man on Con A and up to ten binding sites for p-NP-α-L-Fuc on AAL [45,46],
these results indicated that 34% of the sites on Con A and 48% of those on AAL were active
after immobilization and/or available for binding to the given applied solutes [44].
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The dynamic loading capacity for each type of lectin microcolumn was determined by
injecting a fixed volume containing various concentrations of AGP. Because the injection
volume directly contributed to band-broadening, the injection volume was selected to
provide an area for the retained peak of AGP that could be easily resolved from the nonretained fraction and reliably measured. For a Con A microcolumn, an injection volume of
20 μL was employed under isocratic conditions; this value was 9.5% of the volume for the
first eluting fraction of AGP and 0.9% of the volume for the more highly retained fraction of
AGP under isocratic conditions, as calculated by using the known injection volume and the
measured peak volumes. A sample volume of 100 μL was used for an AAL microcolumn
under step elution conditions, which was 32% of the peak volume for the first eluting AGP
fraction and 38% of the volume for the highly retained fraction.
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The results of the dynamic loading capacity studies are shown in Figure 1. The area of the
retained peak for AGP on a 2.1 mm i.d. × 5.0 cm Con A microcolumn (the second peak in
Figure 2), as measured at 0.10 mL min−1 (i.e., a flow rate within the range considered in
Section 3.2 for use with this type of microcolumn), gave a linear increase up to at least a
dynamic loading capacity of 200 μg (or 4.8 nmol) AGP. This value was 5.4% of the total
loading capacity that had been measured by frontal analysis and was at least 2.7-fold higher
than a binding capacity that has been reported for another glycoprotein (i.e., horseradish
peroxidease) on a 1.0 mm i.d. × 5.0 cm Con A microcolumn that was based on nonconventional macroporous silica [34]. The area of the retained peak for AGP on a 2.1 mm
i.d. × 5.0 cm AAL microcolumn (the second peak in Figure 5), as determined at 0.20 mL
min−1 (i.e., a flow rate within the range considered later in Section 3.4), increased in a
similar linear fashion up to a dynamic loading capacity of 100 μg (or 2.4 nmol) AGP; only
slight deviations from linearity were seen up to 200 μg AGP and even 1000 μg could be
applied to this type of column under non-linear conditions. A value of 100 μg was 1.6% of
the total measured loading capacity that was acquired by frontal analysis for an AAL
microcolumn. Based on these data, all later studies used a sample load of less than 4.8 nmol
AGP for the Con A microcolumn and less than 2.4 nmol AGP for the AAL microcolumn,
with less than half of these amounts typically being used in the following sections.
Anal Chim Acta. Author manuscript; available in PMC 2020 October 31.
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Con A microcolumns have been used in a number of studies with step elution methods and
strongly-retained glycoproteins such as horseradish peroxidase, ribonuclease B and various
agents from serum [34,39,47]. However, it was found in this report that the binding of Con
A to AGP was sufficiently weak to allow the separation of AGP glycoforms into two peaks
under isocratic conditions (Note: no additional elution of AGP was observed when a
competing agent such as methyl α-D-mannopyranoside was then added to the mobile phase,
as has been employed in some prior work with AGP and Con A columns) [24]. The isocratic
separation of AGP glycoform fractions is illustrated in Figure 2 at 25 °C when using a
mobile phase that consisted of 10 mM Tris-HCl buffer (pH 7.4) containing 0.15 M NaCl,
0.50 mM CaCl2, 0.50 mM MgCl2 and 0.50 mM MnCl2. The isocratic elution of the retained
fraction for AGP (i.e., peak 2 in Figure 2), which contained biantennary complex-type Nglycans, was possible due to the moderate binding strength of Con A towards such groups
[27] (Note: the presence of five glycosylation sites on AGP means that some of the retained
AGP also contained tri- and tetra-antennary N-glycans in addition to bi-antennary glycans)
[24]. The average retention factor for this retained fraction, and at the flow rates used in
Figure 2, was 6.43 (± 0.08). The other glycoform fraction for AGP (peak 1) had only weak
or negligible retention, with an average retention factor of 0.19 (± 0.01). The separation
factor (α, or the ratio of the retention factors) for these two peaks was 33.8 (± 1.8). The
~45% portion of normal AGP that was found to be retained by the Con A microcolumn in
this example was consistent with a range 40–55% that has been reported in previous studies
for normal AGP when using Con A columns based on low-performance media [23–26].
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Figure 2 also shows the effect of flow rate on the separation of these two AGP fractions on a
Con A microcolumn. Reducing the flow rate over a representative range of 100 to 50 μL min
−1 gave a 1.3-fold increase in resolution approaching a baseline separation; using 25 μL min
−1 gave a further 1.1-fold increase in resolution but also resulted in longer analysis times.
This increase in resolution was the result of an increase in efficiency for both the first eluting
AGP peak (i.e., plate numbers of 18.6, 34 and 49 at 100, 50 and 25 μL min−1, respectively)
and the second, more strongly retained peak (i.e., plate numbers of 4.8, 6.6 and 8.2). The
decrease in flow rate also produced a lower back pressure (i.e., 435, 290 or 130 psi at 100,
50 or 25 μL min−1) and a corresponding increase in the separation time (from ~18 to 35 or
70 min).
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Because the apparent peak width when shown on a time scale is affected by flow rate, the
peak widths in terms of volume were also used to compare the two AGP fractions [48]. It
was found that the peak volume for AGP peak 1 decreased by up to 1.8-fold over the flow
range that was examined (i.e., from 0.29 to 0.21 or 0.16 mL when the flow rate was
decreased from 100 to 50 or 25 μL min−1). The peak volume for AGP peak 2 was lowered
by up to 1.3-fold under the same conditions (i.e., from 2.26 to 2.06 or 1.68 mL), as is
reflected by the observed increase in resolution between the AGP peaks in Figure 2. Based
on all of these results, a flow rate of 50 μL min−1 was used with Con A microcolumns in the
following sections as a compromise between the analysis time and resolution that were
obtained in the separation of the retained and non-retained AGP glycoform fractions.
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The effect of temperature on the retention of AGP fractions by Con A was also evaluated.
Temperatures spanning up to 50 °C were considered, which are conditions at which the
conformation of AGP has been shown to be stable for up to 6 days [53]. An increase in
temperature from 10 to 50 °C reduced the average retention time of the retained peak for
AGP from 29 to 12 min, as is shown in Figure 3(a) and the Supplementary Material. The
elution time of peak 1 for AGP, which was non-retained or only weakly retained, remained
essentially constant under the same conditions. Overall, a change in temperature from 10 to
50 °C resulted in a 1.4-fold increase in resolution for the two AGP peaks (i.e., going from a
resolution of 0.65 to 0.93) and a 3-fold decrease in separation time (i.e., from 60 to 20 min).
This change in binding with temperature was at least partly due to the change in the free
energy from entropy but may have also been affected by alterations in the structure/
conformation of Con A or AGP [51–53]. There was also a decrease in the back pressure
from 2.0 to 1.2 MPa (290 to 174 psi) due to the lower viscosity of the mobile phase as the
temperature was increased.
The observed change in the retention factor for AGP peak 2 was used to estimate the global
affinity constant (nKa’) between Con A and this glycoform fraction over the temperature
range that was studied. This was accomplished by using Eq. (1) along with the measured
retention factor (k) for peak 2, the void volume of the column (VM) and the total moles of
active binding sites for AGP in the column (mL, as estimated by using data for ovalbumin see Supplementary Material) [31].
k=

nK a′mL
VM

(1)
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The results are summarized in Table 1. It was assumed in these calculations that the value of
mL did not change significantly over a temperature range of 10 to 50 °C. It was found
through this approach that the global affinity constant for the retained AGP fraction on the
Con A microcolumn decreased by 3.5-fold from ~1.8 × 105 M−1 to 5.0 × 104 M−1 as the
temperature was increased from 10 to 50 °C. A similar change in binding strength (i.e., a
4.5-fold decrease) has been observed between Con A and p-aminophenyl β-D-glucoside in
going from a temperature of 5 to 37 °C [49].
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The effect of column temperature on AGP band-broadening was next evaluated. As shown in
Figure 3(b), the volume of the retained AGP peak was reduced by 6.1-fold in going from 10
to 50 °C, while the volume of the weakly or non-retained AGP fraction remained essentially
constant. This effect was examined more closely by using the method of peak profiling and
Eq. (2) to estimate the net dissociation rate constant (kd) for Con A and the retained AGP
glycoforms under these temperature conditions [50].
HR − HM = Hk = 2

k
1
v
2 k
(k + 1)
d
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In this equation, HR is the total plate height measured for the retained target (i.e., the AGP
glycoforms in peak 2) on immobilized binding agent (i.e., Con A), and HM is the plate
height measured on the same column and under the identical conditions for a non-retained
solute (e.g., sodium nitrate in this study). The term Hk is the plate height contribution due to
stationary phase mass transfer, v is the linear velocity, and k is the retention factor for the
analyte [50].
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As shown in Table 1, an increase in temperature from 10 to 50 °C resulted in a 13-fold
increase in the apparent dissociation rate constant (i.e., from 0.003 to 0.040 s−1) for the
retained AGP glycoforms on a Con A microcolumn. A similar trend has been seen for pnitrophenyl-α-D-glucopyranoside and p-nitrophenyl-α-D-mannopyranoside on larger Con A
columns, which gave a 3- to 5-fold increase in their dissociation rate constants as the
temperature increased from 25 to 50 °C [51]. This change in the dissociation rate, combined
with the 3.6-fold decrease in retention seen for the retained AGP fraction under the same
conditions, corresponded to a 6-fold decrease in band-broadening due to stationary phase
mass transfer and a 5-fold decrease in the total plate height (i.e., from 2.0 to 0.43 cm) when
going from 10 to 50 °C.
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The net result of these temperature effects was that the overall resolution between the AGP
fractions increased by 1.4-fold (from 0.65 to 0.93) on a Con A microcolumn as the
temperature was increased from 10 to 50 °C. This is illustrated in Figure 4 and occurred
because the reduction in band-broadening overcame the decrease in retention for AGP that
was observed under such conditions. Based on the combined observations that were made
for Con A and AGP, a flow rate of 50 μL min−1 and a column temperature of 50 °C were
used in all later experiments as optimized conditions for separating AGP glycoforms. The
two AGP fractions were separated under these conditions, and monitored by an on-line
absorbance detector, within 20 min or less on a 2.1 mm i.d. × 5.0 cm Con A microcolumn,
as demonstrated at the bottom of Figure 3(a). This time corresponded to a total elution
volume of 1.0 mL or less to acquire both the non-retained and retained AGP fractions. In
contrast to this, prior methods for the separation of AGP glycoforms by Con A columns,
including work with both low-performance media and non-conventional macroporous silica,
have required much longer total elution times for the non-retained and retained fractions (80
min) [34] or much larger elution volumes (i.e., 60–75 mL up to more than 120–600 mL)
[23–26].
3.4

Effects of flow rate on separation of AGP glycoforms by AAL microcolumns
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Previous work by others has shown that AAL columns can be used to enrich AGP [34].
However, no prior reports have used AAL to separate AGP glycoforms. It was found in this
current study that an AAL microcolumn could separate AGP glycoforms into two peaks
when using step elution based on the addition of L-fucose as a competing sugar, as is
illustrated in Figure 5. It was possible to use step elution in this situation due to the relatively
strong binding of AAL to fucose residues [41], as are present in some AGP glycoforms [1].
The step elution buffer and competing agent were applied after the non-retained peak had
been completely eluted from the microcolumn. An advantage of using step elution is that it
allowed high resolution (i.e., Rs > 1.5, and typically 6.1 or greater) to be achieved between
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the retained and non-retained AGP glycoforms through control of the time at which the
competing agent was applied. This effect also made it possible to use much higher flow rates
for the AAL microcolumns than were needed under isocratic conditions with the Con A
microcolumn to provide good resolution between retained and non-retained AGP
glycoforms.
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The flow rate employed with an AAL microcolumn affected both the analysis time and
broadening of the AGP peaks. For instance, as shown in Figure 5, an increase in the flow
rate from 0.2 to 0.75 mL min−1 decreased the separation time from 15 to 5 min on a 2.1 mm
i.d. × 50 mm AAL microcolumn, with a corresponding increase in the column back pressure
from 1.9 to 7.0 MPa (275 to 1000 psi). The effect of the flow rate on band-broadening was
examined by looking at the corresponding change in volume for the AGP peaks. This peak
volume increased by 3.3-fold from 0.33 to 1.09 mL for the retained AGP glycoforms (peak
2), while the volume of the non-retained AGP fraction (peak 1) remained essentially
constant at ~0.3 mL. The peak volume ratio for these retained vs. non-retained fractions of
AGP was 1.1 at 0.2 mL min−1 and increased to 4.5 at 0.75 mL min−1. These results
indicated that the retained AGP fraction was much more sensitive than the non-retained
fraction to the effects of flow rate on band-broadening. This was expected because these two
fractions had similar band-broadening processes in the microcolumn except for the
stationary phase mass transfer (i.e., adsorption-desorption kinetics), which was present for
only the retained AGP glycoforms [54]. Based on these results, a flow rate of 0.75 mL min−1
was used in all further studies with AGP and an AAL microcolumn as a compromise
between separation speed and efficiency.
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3.5 Effects of competing agent levels on separation of AGP glycoforms by AAL
microcolumns
A previous report has shown that L-fucose can be employed as a competing agent for the
step elution of retained AGP from a small AAL column [34]. This general type of step
elution is known to be dependent on the concentration of competing agent that is passed
through the column. For instance, Eq. (3) shows how the observed retention factor (k) for an
analyte (A) is affected by the presence of a competing agent (I) for an immobilized binding
agent that has single-site interactions for both A and I [31].
k=

K a . AmL

V M 1 + K a, I [I]

(3)
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In this equation, Ka,I is the association equilibrium constant for the competing agent at its
site of competition with A for the immobilized binding agent, and Ka,A is the association
equilibrium constant for A at this same site. The term VM is again the void volume, [I] is the
mobile phase concentration of the competing agent, and mL is the total moles of common
binding sites for A and I in the column. Eq. (3) indicates that the value of k for A will
decrease as [I] is increased, thus resulting in faster elution of A. This effect is illustrated in
Figure 6(a) for the elution of retained AGP from an AAL microcolumn as the fucose
concentration in the mobile phase is increased from 0.25 to 2.0 mM.
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The effect of altering the fucose concentration on band-broadening for the retained AGP
glycoforms (peak 2) was also examined. The results are shown in Figure 6(b), as obtained on
a 2.1 mm i.d. × 50 mm AAL microcolumn at 0.75 mL min−1. The profile for the elution
peak became sharper as the concentration of L-fucose increased from 0.25 to 2.0 mM, as is
illustrated in Figure 6(a). In addition, the peak volume for the retained AGP fraction
decreased by 1.8-fold under these conditions, from 0.82 to 0.45 mL, as is shown Figure 6(b);
it was also determined from these data that fucose concentrations above 2.0 mM would
provide only a moderate further decrease in this peak volume. Based on these results, a final
concentration of 2.0 mM L-fucose was used for the elution of retained AGP from AAL
microcolumns in all further studies based on these results.
3.6

Effect of temperature on separation of AGP glycoforms by AAL microcolumns
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The effect of temperature on band-broadening was also evaluated for the AGP glycoforms
on an AAL microcolumn. The results are shown in Figure 7 for a 2.1 mm i.d. × 50 mm AAL
microcolumn that was used at 0.75 mL min−1 and with 2.0 mM fucose being employed as a
competing agent for step elution. An increase in temperature from 10 to 50 °C reduced the
peak volume for the retained AGP fractions by 2.6-fold, or from 0.93 to 0.36 mL, as
indicated in Figure 7(a). This change was probably due to an increase in the dissociation rate
of the retained AGP glycoforms from the AAL microcolumn as the temperature was
increased.
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This change in the rate of AGP dissociation from AAL with temperature was examined in
more detail by using peak decay analysis [55–57]. In this method, the apparent dissociation
rate constant (kd) for the retained AGP from an AAL microcolumn was obtained from the
slope of the natural logarithm of the elution profile for AGP, as represented by Eq. (4) [55–
57].
ln

dmE
= ln mE kd − kdt
dt
0

(4)

In this equation, t is the time after initiation of step elution, mE is the moles of analyte that
has been eluted at time t, and mE is the moles of analyte that were initially bound to the
0
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microcolumn. As has been discussed for other systems, this equation assumes that no reassociation of the analyte (i.e., AGP) occurs after it has dissociated from the microcolumn
during the elution step and that this dissociation is the rate limiting step for elution of the
analyte [55–57]. In this study, a flow rate of 0.75 mL min−1 was used during the peak decay
measurements to prevent AGP from re-entering the stagnant mobile phase of the support and
re-associating with AAL during the elution step. In addition, 2 mM L-fucose was present in
the elution buffer and used to block the binding sites of AAL as AGP dissociated from the
microcolumn.
The results that were obtained through the peak decay studies are shown in Figure 7(b) and
Table 2. It was found that the apparent dissociation rate constant for the retained AGP
glycoforms during the elution step increased by 2.3-fold (i.e., from 0.040 to 0.091 s−1) as the
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temperature was increased from 10 to 50 °C. These apparent dissociation rate constants for
AGP from AAL during step elution were 2- to 13-fold higher than those observed in Section
3.3 for AGP glycoforms bound to Con A at the same temperatures but eluted under isocratic
conditions.
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The overall binding activity between the immobilized AAL and AGP was also evaluated at
these temperatures. The area for the retained AGP glycoforms remained at a relatively
constant value over this temperature range, with a maximum value being obtained at 30 °C
and only a slightly decrease of 5.2 to 16% occurring when increasing the temperature further
to 40 or 50 °C, respectively. This indicated that the activity of the immobilized AAL and its
ability to bind to AGP were relatively consistent up to 30 °C and had only a modest decrease
up to 40 or 50 °C (e.g., due to change in the free energy due to entropy or changes in the
conformation of either AAL or AGP with temperature). An increase in temperature from 10
to 50 °C also reduced the back pressure from 8.3 to 5.4 MPa (1200 to 780 psi) for such a
microcolumn.
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The observations made in this section and the previous sections in terms of the role played
by temperature, flow rate and fucose concentration were used to select final conditions for
the AAL microcolumns when separating AGP glycoforms. These conditions included a flow
rate of 0.75 mL min−1, a column temperature of 50 °C, and an elution buffer that contained 2
mM L-fucose as a competing agent. Under these conditions, AGP glycoforms were resolved
into two peaks within 6 min or less (a total elution volume of 4.5 mL or less), as shown in
Figure 7(a). Although little prior work has been done in separating AGP glycoform fractions
by AAL columns, this current method was significantly faster than a previous method that
used a total elution time of 80 min for this glycoprotein [34]. In addition, it was found that
~9% of normal AGP was retained by the AAL microcolumn under the final optimized
conditions. This result was consistent with an estimated binding level of AAL for AGP from
standard serum or healthy control subjects of 18–20% (S.D., ± 3–4%), as determined in a
lower-resolution separation method based on crossed affinoimmunoelectrophoresis [18].
3.7

Con A and AAL microcolumn stability and reproducibility
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In the last stage of this work, the Con A and AAL microcolumns were used under their final
selected conditions and evaluated for their stability and reproducibility. As shown in Table 3,
a Con A microcolumn had within-day precisions (n = 3) for the retention times of the nonretained and retained AGP peaks of ± 0.34% and ± 4.7%. The day-to-day precisions (n = 9,
as representing three measurements made per day over three sequential days) for the same
peaks and their retention times were ± 1.1% and ± 4.0%. The within-day precisions for the
areas of these peaks were ± 0.49% and ± 3.5%, respectively, and their day-to-day precisions
were ± 0.42% and ± 3.0%. The day-to-day precisions for the peak areas agree with a
previously-reported variation for other small Con A columns of less than 5% during the
separation of glycoforms for ribonuclease B [39]. These results indicated that a Con A
microcolumn could provide good reproducibility and stability for the separation and analysis
of AGP glycoforms under the conditions that were used in this study.
Similar levels of precision were obtained with conditions that were used to separate AGP
glycoforms on an AAL microcolumn. The retention time of retained AGP glycoforms was
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controlled by the time at which the elution buffer was applied to the column, which occurred
in these experiments at 2.7 min. In this case, the within-day precisions (n = 3) of the
retention times for the non-retained and retained AGP glycoforms were ± 0.68% and
± 0.27%, and the day-to-day precisions (n = 9) were ± 0.68% and ± 0.18%. The within-day
precisions for the peak areas were ± 3.0% and ± 1.7%, and the day-to-day precisions for
these peak areas were ± 2.2% and ± 1.5%.
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The type of Con A microcolumn that was prepared and used in this study was found to
provide consistent binding to AGP glycoforms containing bi-antennary N-glycans. These
AGP glycoforms had a measured abundance of 45–47% in a standard sample of normal
AGP that was monitored by a Con A microcolumn over the course of fifteen months and at
least 90 sample injection cycles. It was found that the type of AAL microcolumn employed
in this work also gave consistent binding to AGP glycoforms containing fucosylated Nglycans. In this case, these AGP glycoforms were determined on a single AAL microcolumn
to be present at a measured level of 9–10% in a standard sample of normal AGP, as
determined over the course of at least seven months of use and more than 80 sample
injections. These results fit with a previous report that has found small Con A columns could
be employed without any major change in their capture efficiency for ribonuclease B over 30
injections and more than 6 months of operation [39].

4.

Conclusion
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In this report, affinity microcolumns containing Con A or AAL were developed, optimized
and evaluated for the separation of non-retained and retained AGP glycoform fractions.
Factors that were considered in this process include the binding capacity of these
microcolumns and the effects of flow rate, temperature and elution method on these
separations. Techniques that used for this analysis ranged from frontal analysis to zonal
elution, peak profiling, and peak decay analysis. The final conditions selected for the
separation of AGP glycoforms by a Con A microcolumn involved the use of a flow rate of
0.05 mL min−1 and a temperature of 50 °C under isocratic elution conditions, which gave a
separation of non-retained and retained AGP glycoform fractions in less than 20 min. A
separation of non-retained and retained AGP glycoform fractions was obtained in less than 6
min on an AAL microcolumn by using a flow rate of 0.75 mL min−1, a temperature of
50 °C, and 2 mM L-fucose as a competing agent. These separations were significantly faster
than those that have been previously been reported for AGP with other Con A or AAL
columns [23–26,34] and could be followed directly with on-line absorbance detector.
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Both types of lectin microcolumns had good reproducibility in terms of their retention times
and peak areas for the AGP glycoform fractions. For instance, the inter-day precision was
less than 4.0% for the retention times and less than 3.0% for the peak areas on a Con A
microcolumn. For AAL microcolumn, the inter-day precision was less than 0.7% for the
retention time and less than 2.2% for the peak areas. It was also found that these
microcolumns had good long term stabilities and reasonably low back pressures. All of these
features should make microcolumns valuable in future work to examine structural variations
in AGP that has been isolated from natural samples representing various disease states (e.g.,
by immunoaffinity chromatography) [3–12] and in use with other approaches, such as off-
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line coupling with capillary electrophoresis or mass spectrometry [26,34], to allow the multidimensional analysis of AGP glycoforms. The same methods and microcolumns should also
be useful in examining other glycoproteins that may have glycans that can bind to Con A or
AAL [34].
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•

Lectin microcolumns were created to separate glycoforms of alpha1-acid
glycoprotein.

•

Concanavalin A (Con A) and Aleuria Aurantia lectin (AAL) were used as
binding agents.

•

Frontal analysis, peak decay analysis and peak profiling were used for column
evaluation.

•

Glycoforms were separated in less than 20 min by Con A and less than 6 min
by AAL.

•

An increase in column temperature reduced band-broadening and overall
analysis times.
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Figure 1.
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Characterization of the dynamic loading capacity for AGP on 2.1 mm i.d. × 50 mm
microcolumns containing (a) Con A or (b) AAL. The error bars represent a range of ± 1 S.D.
(n = 3), and peak areas are expressed in relative units. The conditions used in (a) for the Con
A microcolumn were as follows: injection volume, 20 μL; flow rate, 0.10 mL min−1;
temperature, 25 °C; mobile phase used for isocratic elution, 10 mM Tris-HCl buffer (pH 7.4)
containing 0.15 M NaCl, 0.50 mM CaCl2, 0.50 mM MgCl2 and 0.50 mM MnCl2. The
conditions in (b) for the AAL microcolumn were as follows: injection volume, 100 μL; flow
rate, 0.20 mL min−1; temperature, 25 °C; application buffer, 10 mM Tris-HCl buffer (pH
7.4) containing 0.15 M NaCl; elution buffer, same composition as the application buffer plus
1 mM L-fucose.
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Figure 2.

Chromatograms obtained for AGP on a 2.1 mm i.d. × 50 mm Con A microcolumn at various
flow rates. Conditions: amount of injected AGP, 200 μg; temperature, 25 °C. Other
conditions were the same as in Figure 1(a).
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Figure 3.

(a) Chromatograms obtained for AGP on a 2.1 mm i.d. × 50 mm Con A microcolumn at
various temperatures and (b) the volume of peaks 1 and 2 for AGP on the Con A
microcolumn at the tested temperatures. Conditions: amount of injected AGP, 100 μg; and
flow rate, 50 μL min−1. Other conditions were the same as in Figure 1(a). The error bars
represent a range of ± 1 S.D. (n = 3).
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Figure 4.

Resolution measured between the non-retained and retained peaks for AGP on a 2.1 mm ×
50 mm Con A microcolumn at various temperatures. Other conditions are the same as in
Figure 3. The error bar represent ± 1 S.D. (n = 3).
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Figure 5.

Chromatograms obtained for AGP on a 2.1 mm × 50 mm AAL microcolumn at various flow
rates. Conditions: injection volume, 20 μL of 1.5 mg mL−1 AGP (30 μg); column
temperature, 25 °C; application buffer, 10 mM Tris-HCl buffer (pH 7.4) containing 0.15 M
NaCl; elution buffer, same as the application buffer but with the addition of 1 mM L-fucose.
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Figure 6.

(a) Chromatograms for AGP on a 2.1 mm × 50 mm AAL microcolumn and (b) volume of
the retained AGP peak in the presence of various concentrations of L-fucose as a competing
agent. Chromatographic condition: flow rate, 0.75 mL min−1; application buffer: 10 mM
Tris-HCl buffer (pH 7.4) containing 0.15 M NaCl; elution buffer, same as the application
buffer but with the addition of 0.25 to 2.0 mM L-fucose. Other conditions are the same as in
Figure 5. The error bar stands for ± 1 S.D. (n = 3).
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Figure 7.

(a) Chromatograms and (b) natural logarithm of elution profile of AGP on a 2.1 mm × 50
mm AAL microcolumn at various temperatures. Conditions: sample, 20 μL AGP with a
concentration of 1.5 mg mL−1; flow rate, 0.75 mL min−1; application buffer: 10 mM TrisHCl buffer (pH 7.4) containing 0.15 M NaCl; elution buffer, same as the application buffer
but with the addition of 2.0 mM L-fucose.
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0.32 (± 0.04)

0.50 (± 0.06)

0.86 (± 0.05)

1.42 (± 0.09)

1.89 (± 0.07)

Hk, cm

2.52 (± 0.20)

3.55 (± 0.19)

4.94 (± 0.27)

6.56 (± 0.07)

8.95 (± 0.32)

k

0.0397 (± 0.0051)

0.0216 (± 0.0025)

0.0103 (± 0.0007)

0.0051 (± 0.0003)

0.0030 (± 0.0001)

kd, s−1

5.0 (± 0.6)

7.0 (± 0.7)

9.7 (± 1.0)

12.9 (± 1.2)

17.6 (± 1.7)

nKa’, × 104 M−1

a

s−1. The globe affinity constant (nKa’) was calculated by using Eq. (1) along with an mL value of 6.7 (± 0.6) nmol and a value for VM of 0.132 mL for the Con A microcolumn.

The values in the parentheses represents ± 1 S.D. The value of HM that was used with Eq. (2) to obtain the dissociation rate constant (kd) was equal to 0.111 (± 0.003) cm, and the value of v was 0.032 cm

a

0.43 (± 0.04)

0.97 (± 0.05)

30

0.61 (± 0.06)

1.53 (± 0.09)

20

50

2.00 (± 0.07)

10

40

HR, cm

T, °C

Estimated dissociation rate constants and global affinity constants for retained AGP glycoforms on a Con A microcolumn
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The values in the parentheses represent ± 1 S.D.

a

0.091 (± 0.002)

0.061 (± 0.002)

30

50

0.050 (± 0.001)

20

0.075 (± 0.001)

0.040 (± 0.001)

10

40

kd, s−1

T, °C

Dissociation rate constants (kd) estimated by the peak decay method for retained AGP glycoforms on an AAL microcolumn
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a

± 0.68%
± 0.27%

Retained AGP glycoforms (peak 2)

± 4.7%

Non-retained AGP glycoforms (peak 1)

AAL microcolumn

Retained AGP glycoforms (peak 2)

± 0.34%

± 0.18%

± 0.68%

± 4.0%

± 1.1%

Day-to-day (n = 9)

± 1.7%

± 3.0%

± 3.5%

± 0.49%

Within-day (n = 3)

± 1.5%

± 2.2%

± 3.0%

± 0.42%

Day-to-day (n = 9)

Precision of peak area

The listed values are ranges of ± 1 R.S.D. The day-to-day precisions represent three measurements made per day over three days.

a

Con A microcolumn

Non-retained AGP glycoforms (peak 1)

Within-day (n = 3)

Precision of retention time

Precisions of retention times and areas for retained and non-retained AGP peaks on Con A and AAL microcolumns
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